A Time to Event Tutorial for Pharmacometricians
Open Access
- 15 May 2013
- journal article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 2 (5), 1-8
- https://doi.org/10.1038/psp.2013.18
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Mayan Doomsday’s effect on survival outcomes in clinical trialsCMAJ : Canadian Medical Association Journal, 2012
- Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2012
- Authors' response to Marras and Oakes, ‘piecing together the puzzle of progression and mortality in Parkinson's disease’British Journal of Clinical Pharmacology, 2012
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseBritish Journal of Clinical Pharmacology, 2012
- Progression of motor and nonmotor features of Parkinson's disease and their response to treatmentBritish Journal of Clinical Pharmacology, 2012
- Disease Progression and Pharmacodynamics in Parkinson Disease – Evidence for Functional Protection with Levodopa and Other TreatmentsJournal of Pharmacokinetics and Pharmacodynamics, 2006
- Drug Treatment Effects on Disease ProgressionAnnual Review of Pharmacology and Toxicology, 2001
- Mortality in DATATOP: A Multicenter trial in early Parkinson's diseaseAnnals of Neurology, 1998
- Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's diseaseBMJ, 1995
- XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &cPhilosophical Transactions of the Royal Society of London, 1825